Range
4.14 - 4.4
Vol / Avg.
298.2K/283.7K
Div / Yield
-
52 Wk
4.05 - 7.55
Mkt Cap
131M
Payout Ratio
-
Open
4.35
P/E
-
EPS
-0.79
Shares
31.3M
Outstanding
31.3M
Total Float
31.2M
load more
Sector: Health Care.Industry: Biotechnology
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.640-0.790 -0.1500
REV970.000K1.467M497.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CBIOCatalyst Biosciences0%131M

Catalyst Biosciences Frequently Asked Questions

Q

How do I buy Catalyst Biosciences (CBIO) stock?

A

You can purchase shares of Catalyst Biosciences (NASDAQ: CBIO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Catalyst Biosciences's (CBIO) competitors?

Q

What is the target price for Catalyst Biosciences (CBIO) stock?

A

The latest price target for Catalyst Biosciences (NASDAQ: CBIO) was reported by Raymond James on April 29, 2021. The analyst firm set a price target for 19.00 expecting CBIO to rise to within 12 months (a possible 354.55% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Catalyst Biosciences (CBIO)?

A

The stock price for Catalyst Biosciences (NASDAQ: CBIO) is $4.18 last updated Today at 8:00:03 PM.

Q

Does Catalyst Biosciences (CBIO) pay a dividend?

A

There are no upcoming dividends for Catalyst Biosciences. The last dividend paid out to investors was $0.00 on August 20, 2015.

Q

When is Catalyst Biosciences (NASDAQ:CBIO) reporting earnings?

A
Catalyst Biosciences’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Catalyst Biosciences (CBIO) going to split?

A

There is no upcoming split for Catalyst Biosciences.

Q

What sector and industry does Catalyst Biosciences (CBIO) operate in?

A

Catalyst Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.